Inflection Biosciences’ management team brings together over 30 years of industry experience gained within large and small pharma, comprising expertise in small molecule drug development, intellectual property management, business development and fund raising.

Darren Cunningham, Co-Founder and Chief Executive Officer

1 DC pic Thumbnail0Darren Cunningham has 17 years senior management experience in life science companies. Darren spent 8 years at Amarin Corporation plc in a range of senior positions with responsibility covering business and corporate development – comprising in-licensing, out-licensing, M&A, divestitures, deal negotiation; strategic planning, global intellectual property management, investor relations, fundraising, financial reporting and operations management. Prior to Amarin, Darren was an Associate Director of Strategic Planning at publicly quoted drug company Elan Corporation plc.
Darren holds a Bachelor of Commerce Degree from the National University of Ireland Galway, and a Masters in Accountancy from the Michael Smurfit Business School, University College Dublin. He trained at PricewaterhouseCoopers and is a Fellow of the Institute of Chartered Accountants in Ireland. He is also Adjunct Professor at the School of Biomolecular and Biomedical Science, University College Dublin.

Dr. Michael O’Neill, Co-Founder and Director of R&D

MON pic Thumbnail0Dr. O’Neill has more than 20 years’ experience working in the pharmaceutical industry. He was a Senior Research Scientist and Portfolio Manager at Eli Lilly for much of this time where he was responsible for developing project plans for the selection of projects and for their progression from discovery through to important development milestones. Dr. O’Neill established his own consulting business, Eolas, to help early stage companies to organize their research along commercial lines, becoming accomplished at building highly streamlined development plans. He has built consortia of commercial and academic groups to apply for major EU grants. Previously Dr. O’Neill was Head of Laboratory at Almirall and a Research Neuroscientist at Merck. He has authored over 80 papers, book chapters, patents and abstracts and is Honorary Visiting Senior Lecturer at the Science Policy Research Unit at the University of Sussex. He holds a BA Psychology from UCC and a PhD from QUB Belfast.

Tess Barker PhD, Project Manager 

Tess (conusltant) has nearly 20 years project management experience in the biotech/pharma industry. She has worked at companies including KS Biomedix, Microscience and Cambridge Antibody Technology before setting up her own consultancy business. Tess’ experience is focussed largely on the management of oncology projects as they progress through development into initial clinical studies, mostly with virtual or semi-virtual teams. Tess has a BSc in chemistry from the University of York and a PhD from the University of Birmingham.



Search - Use spaces to separate your keywords
Inflection Biosciences. Suite 15, Anglesea House Carysfort Avenue, Blackrock,  Co. Dublin.  

 Company registration no. 509046.

© 2019 Inflection Biosciences.   Web Design by Webtrade